Cohen, Romain <br/><br/>
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment].  [electronic resource] 

 -  Bulletin du cancer  Apr 2020 
 - 438-446 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article 
<br/><br/><label>ISSN: </label>1769-6917 
<br/><br/><label>Standard No.: </label>10.1016/j.bulcan.2019.11.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Chemotherapy, Adjuvant<br/>Clinical Trials, Phase II as Topic<br/>DNA Mismatch Repair<br/>Disease-Free Survival<br/>Humans<br/>Ipilimumab--therapeutic use<br/>Microsatellite Instability<br/>Multicenter Studies as Topic<br/>Neoadjuvant Therapy--methods<br/>Nivolumab--therapeutic use<br/>Patient Selection<br/>Perioperative Care<br/>Phenotype<br/>Stomach Neoplasms--drug therapy<br/>Treatment Outcome